Who bought Tylenol-maker Kenvue?
Asked 12 hours ago
Answer
Kimberly-Clark, the maker of Huggies and Kleenex, agrees to acquire Kenvue, the parent company of Tylenol, in a deal valued at nearly $50 billion. The acquisition is set to create a major consumer health company and is expected to close in the latter half of the upcoming year, pending shareholder and government approval.
Now Playing
- Kimberly-Clark is set to acquire Kenvue, Tylenol's parent company, for nearly $50 billion. 4s
 - The deal is expected to close in the second half of 2026, pending shareholder and government approval. 23s
 - Kimberly-Clark shareholders will own 54% of the combined company, with Kenvue shareholders holding 46%. 38s
 - The merged company is projected to generate $32 billion in annual revenue and achieve $1.9 billion in cost savings. 48s
 - Following the announcement, Kenvue's stock rose over 15%, while Kimberly-Clark's stock fell more than 13%. 1m 40s
 
